EBOV-GP-IN-1 (Compound 28) is a potent small-molecule inhibitor that blocks Ebola virus entry by targeting the viral envelope glycoprotein (EBOV-GP), exhibiting an IC50 of 0.05 μM. This compound is a valuable research tool for studying viral entry mechanisms and for antiviral development in both in vitro and in vivo experimental models.